Neoplasm Treatment - Mexico

  • Mexico
  • In Mexico, the Neoplasm Treatment market is expected to experience significant growth in the coming years.
  • By 2024, the projected revenue is estimated to reach US$3.85bn.
  • This indicates a positive trend in the market, which is further expected to continue with an annual growth rate of 3.85% from 2024 to 2029.
  • By the end of 2029, the market volume is projected to reach US$4.65bn.
  • When comparing Mexico's revenue in the Neoplasm Treatment market to other countries globally, it is noteworthy that in the United States is expected to generate the most revenue.
  • In 2024, the projected revenue for the United States is estimated to be US$90.56bn.
  • This indicates the dominant position of the United States in terms of market size and revenue generation within this segment.
  • Mexico's neoplasm treatment market is witnessing a surge in demand for advanced immunotherapies and targeted therapies.

Key regions: India, Japan, United States, United Kingdom, Germany

Region comparison


Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.


  • Revenue
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)